Salicylates - Dosage - Side Effects - Drug Interactions - Warnings
- A - Z: Arthritis Drugs
- A - Z: Drug Costs
- A - Z: Joint Pain
- A - Z: NSAIDs
- A - Z: Pain Relief
- Aspirin ASA (Bayer, Anacin) (20)
- Doan's Pills (Novasal)
- Magnesium Salicylate (13)
- Salsalate (Disalcid) (11)
- Topical Salicylates
- Trilisate (CMTrisalicylate) (12)
What Are Salicylates? When Are Salicylates Prescribed To Treat Arthritis?
What are salicylates? When are salicylates prescribed to treat arthritis? Do salicylates carry the same cardiovascular risk as nonselective NSAIDs and COX-2 selective inhibitors?
Facts About NSAIDs
NSAIDs are prescribed to reduce inflammation associated with arthritis.
What Are NSAIDs?
NSAIDs are commonly prescribed arthritis medications.
FDA Announces Changes For All NSAIDs
Following scrutiny of the class of arthritis drugs known as NSAIDS and COX-2 inhibitors, the FDA has taken action.
Inflammation - Test Your Knowledge
Inflammation is a process associated with many diseases, including arthritis. Do you know what is happening as inflammation occurs? Do you know why inflammation occurs?
Drug Profile: Salicylates
Drug profile and essential information on Salicylates, from UMM.
Aspirin and Related Drugs (Salicylates)
Salicylates are a family of related drugs that reduce pain and inflammation. The word salicylate refers to the active ingredient in the drugs. Aspirin (acetylsalicylic acid or ASA) is one of these drugs. Many of the others are chemically related to aspirin. Salicylates differ from each other slightly in chemical structure, but have similar effects in the body, from University of Washington.
Reye Syndrome: A Serious, Often Fatal, Nervous System Disorder
Since the use of aspirin and aspirin-containing products is associated with increased risk of Reye syndrome, experts recommend these medicines not be given to children or teenagers who have the flu, an illness with a fever, or chicken pox. Most (90%) of those affected by Reye syndrome are under age 15, but it may also affect teenagers and adults.
